Insulin-like growth factor (IGF) axis in cancerogenesis
Abstract
Determination of the role of insulin-like growth factor (IGF) family components in carcinogenesis of several human tumors is based on numerous epidemiological and pre-clinical studies, experiments in vivo and in vitro and on attempts at application of drugs affecting the IGF axis. Investigative hypotheses in original studies were based on biological functions manifested by the entire family of IGF (ligands, receptors, linking proteins, adaptor molecules). In the context of carcinogenesis the most important functions of IGF family involve intensification of proliferation and inhibition of cell apoptosis and effect on cell transformation through synthesis of several regulatory proteins. IGF axis controls survival and influences on metastases of cells. Interactions of IGF axis components may be of a direct or indirect nature. The direct effects are linked to activation of PI3K/Akt signaling pathway, in which the initiating role is first of all played by IGF-1 and IGF-1R. Activity of this signaling pathway leads to an increased mitogenesis, cell cycle progression, and protection against different apoptotic stresses. Indirect effects of the axis depend on interactions between IGF and other molecules important for cancer etiology (e.g. sex hormones, products of suppressor genes, viruses, and other GFs) and the style of life (nutrition, physical activity). From the clinical point of view, components of IGF system are first of all considered as diagnostic serous and/or tissue biomarkers of a given cancer, prognostic factors and attractive target of modern anti-tumor therapies. Several mechanisms in which IGF system components act in the process of carcinogenesis need to be clarified, mainly due to multifactorial etiology of the neoplasms. Pin-pointing of the role played in carcinogenesis by any single signaling pathway remains particularly difficult. The aim of this review is to summarize the current data of several epidemiological studies, experiments in vitro and on animal models, to increase our understanding of the complex role of IGF family components in the most common human cancers.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Animal protein increases insulin-like growth factor 1, which is implicated in carcinogenesis.
“Animal protein has been indicated to increase insulin-like growth factor 1, which is implicated in carcinogenesis [70,87].”
From A Cross-Talk between Diet and the Oral Microbiome: Balance of Nutrition on Inflammation and Immune System’s Response during Periodontitis (2022) · cites this paper as [87]
Cites
2 retracted
Genua, M., Xu, S., Buraschi, S., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040148 · Cited by 25 · see citing works
RetractedInsulin-like growth factor 1 promotes growth of gastric cancer by inhibiting foxo1 nuclear retention
Li, S., Lei, X., Zhang, J., Yang, H., Liu, J., & Xu, C. (2015) · Tumor Biology · doi:10.1007/s13277-015-3096-9 · Cited by 13 · see citing works
RetractedHallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219 · see citing works
Human papillomavirus and cervical cancer
SCHIFFMAN, M. H., Castle, P. E., Jerónimo, J., Rodríguez, A. C., & Wacholder, S. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61416-0 · Cited by 3,046 · see citing works
Breast and Ovarian Cancer Risks Due to Inherited Mutations in <i>BRCA1</i> and <i>BRCA2</i>
King, M.-C., Marks, J. H., & Mandell, J. B. (2003) · Science · doi:10.1126/science.1088759 · Cited by 2,229 · see citing works
Variation in cancer risk among tissues can be explained by the number of stem cell divisions
Tomasetti, C., & Vogelstein, B. (2015) · Science · doi:10.1126/science.1260825 · Cited by 1,927 · see citing works
Role of the Insulin-Like Growth Factor Family in Cancer Development and Progression
Yu, H. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.18.1472 · Cited by 1,433 · see citing works
The Somatomedin Hypothesis: 2001
Roith, D. L., Bondy, C. A., Yakar, S., Liu, J., & Butler, A. A. (2001) · Endocrine Reviews · doi:10.1210/edrv.22.1.0419 · Cited by 1,258 · see citing works
Ma, J., Pollak, M., Giovannucci, E. L., Chan, J. M., Tao, Y., Hennekens, C. H., & Stampfer, M. J. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.7.620 · Cited by 1,118 · see citing works
The Insulin-Like Growth Factor-Binding Protein (IGFBP) Superfamily
Hwa, V., Oh, Y., & Rosenfeld, R. G. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0382 · Cited by 1,076 · see citing works
Croce, C. M. (2008) · New England Journal of Medicine · doi:10.1056/nejmra072367 · Cited by 1,055 · see citing works
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
Samani, A. A., Yakar, S., LeRoith, D., & Brodt, P. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0001 · Cited by 999 · see citing works
The Effects of Insulin-Like Growth Factors on Tumorigenesis and Neoplastic Growth
Khandwala, H. M., McCutcheon, I. E., Flyvbjerg, A., & Friend, K. E. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.3.0399 · Cited by 842 · see citing works
The role of signaling pathways in the development and treatment of hepatocellular carcinoma
Whittaker, S. R., Marais, R., & Zhu, A. X. (2010) · Oncogene · doi:10.1038/onc.2010.236 · Cited by 824 · see citing works
Fukuda, R., Hirota, K., Fan, F., Jung, Y. D., Ellis, L. M., & Semenza, G. L. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m203781200 · Cited by 815 · see citing works
Kaaks, R. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1592 · Cited by 655 · see citing works
Key, T. J. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70095-4 · Cited by 653 · see citing works
The IGF‐1 receptor in cancer biology
Baserga, R., Peruzzi, F., & Reiss, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11487 · Cited by 643 · see citing works
Plasma Levels of Insulin-Like Growth Factor-I and Lung Cancer Risk: a Case-Control Analysis
Yu, H., Spitz, M. R., Mistry, J., Gu, J., Hong, W. K., & Wu, X. Y. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.2.151 · Cited by 554 · see citing works
Roles for Growth Factors in Cancer Progression
Witsch, E., Sela, M., & Yarden, Y. (2010) · Physiology · doi:10.1152/physiol.00045.2009 · Cited by 525 · see citing works
Graham, T. R., Zhau, H. E., Odero-Marah, V., Osunkoya, A. O., Kimbro, K. S., Tighiouart, M., Liu, T., Simons, J. W., & O'Regan, R. M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2559 · Cited by 385 · see citing works
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
Wu, Y., Yakar, S., Zhao, L., Hennighausen, L. G., & LeRoith, D. (2002) · PubMed · Cited by 380 · see citing works
Hellawell, G. O., Turner, G. D. H., Davies, D. R., Poulsom, R., BREWSTER, S. F., & Macaulay, V. M. (2002) · PubMed · Cited by 376 · see citing works
Gene methylation in gastric cancer
Qu, Y., Dang, S., & Hou, P. (2013) · Clinica Chimica Acta · doi:10.1016/j.cca.2013.05.002 · Cited by 374 · see citing works
The Role of the IGF System in Cancer: From Basic to Clinical Studies and Clinical Applications
Moschos, S. J., & Mantzoros, C. S. (2002) · Oncology · doi:10.1159/000066230 · Cited by 371 · see citing works
The IGF system and breast cancer.
Sachdev, D., & Yee, D. (2001) · Endocrine Related Cancer · doi:10.1677/erc.0.0080197 · Cited by 315 · see citing works
Maloney, E. K., McLaughlin, J. L., Dagdigian, N. E., Garrett, L. M., Connors, K. M., Zhou, X., Blättler, W. A., Chittenden, T. D., & Singh, R. (2003) · PubMed · Cited by 307 · see citing works
Bergmann, U., Funatomi, H., Yokoyama, M., Beger, H. G., & Korc, M. (1995) · PubMed · Cited by 304 · see citing works
Livingstone, C. (2013) · Endocrine Related Cancer · doi:10.1530/erc-13-0231 · Cited by 296 · see citing works
Warren, R. S., Yuan, H., Matli, M. R., Ferrara, N., & Donner, D. B. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.46.29483 · Cited by 274 · see citing works
Gunter, M. J., Hoover, D. R., Yu, H., Wassertheil-Smoller, S. W., Manson, J. E., Li, J., Harris, T. G., Rohan, T. E., Xue, X., Ho, G., et al. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2686 · Cited by 268 · see citing works
Nakanishi, Y., Mulshine, J. L., Kasprzyk, P. G., et al. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113594 · Cited by 252 · see citing works
Expression and distribution of insulin-like growth factor-1 receptor in human carcinomas
Ouban, A., Muraca, P. J., Yeatman, T. J., & Coppola, D. (2003) · Human Pathology · doi:10.1016/s0046-8177(03)00291-0 · Cited by 251 · see citing works
Caro, J. F., Poulos, J., Ittoop, O. R. R., Pories, W. J., Flickinger, E. G., & Sinha, M. K. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113451 · Cited by 249 · see citing works
Rinaldi, S., Cleveland, R. J., Norat, T., Biessy, C., Rohrmann, S., Linseisen, J., Boeing, H., Pischon, T., Panico, S., Agnoli, C., et al. (2009) · International Journal of Cancer · doi:10.1002/ijc.24927 · Cited by 241 · see citing works
Tanno, S., Testa, J. R., & KOHGO, Y. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)80193-1 · Cited by 230 · see citing works
Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations
Mohan, S. V., & Chang, A. L. S. (2014) · Current Dermatology Reports · doi:10.1007/s13671-014-0069-y · Cited by 228 · see citing works
Obesity, the PI3K/Akt signal pathway and colon cancer
Huang, X., & Chen, J. (2009) · Obesity Reviews · doi:10.1111/j.1467-789x.2009.00607.x · Cited by 224 · see citing works
Tovar, V., Alsinet, C., Villanueva, A., Hoshida, Y., Chiang, D. Y., Solé, M., Thung, S. N., Moyano, S., Toffanin, S., Mínguez, B., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.01.015 · Cited by 223 · see citing works
The key role of growth hormone–insulin–IGF-1 signaling in aging and cancer
Anisimov, V. N., & Bartke, A. (2013) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2013.01.005 · Cited by 222 · see citing works
Small Is Beautiful: Insulin-Like Growth Factors and Their Role in Growth, Development, and Cancer
Maki, R. G. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5040 · Cited by 217 · see citing works
The Insulin-Like Growth Factor System in Cancer
Weroha, S. J., & Haluska, P. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.04.014 · Cited by 213 · see citing works
Ellis, B. C., Graham, L. D., & Molloy, P. L. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2013.10.016 · Cited by 210 · see citing works
Chan, W. K., Klock, G., & Bernard, H. (1989) · Journal of Virology · doi:10.1128/jvi.63.8.3261-3269.1989 · Cited by 208 · see citing works
Cariani, E., Lasserre, C., Seurin, D., Hamelin, B., Kemeny, F., Franco, D., Czech, M., Ullrich, A., & Bréchot, C. (1988) · PubMed · Cited by 193 · see citing works
Matheny, R. W., Nindl, B. C., & Adamo, M. L. (2010) · Endocrinology · doi:10.1210/en.2009-1217 · Cited by 186 · see citing works
The Insulin/IGF System in Colorectal Cancer Development and Resistance to Therapy
Vigneri, P. G., Tirrò, E., Pennisi, M. S., Massimino, M., Stella, S., Romano, C., & Manzella, L. (2015) · Frontiers in Oncology · doi:10.3389/fonc.2015.00230 · Cited by 186 · see citing works
HPV-Associated Head and Neck Cancer
Vokes, E. E., Agrawal, N., & Seiwert, T. Y. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv344 · Cited by 184 · see citing works
Akagi, Y., Liu, W., Zebrowski, B. K., Xie, K., & Ellis, L. M. (1998) · PubMed · Cited by 183 · see citing works
DiGiovanni, J., Bol, D. K., Wilker, E., Beltrán, L., Carbajal, S., Moats, S., Ramı́rez, Á., Jorcano, J. L., & Kiguchi, K. (2000) · PubMed · Cited by 177 · see citing works
Stoeltzing, O., Liu, W., Reinmuth, N., Fan, F., Parikh, A. A., Bucana, C. D., Evans, D. B., Semenza, G. L., & Ellis, L. M. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63460-8 · Cited by 175 · see citing works
Bowers, L. W., Rossi, E. L., Oâ€TMFlanagan, C. H., deGraffenried, L. A., & Hursting, S. D. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00077 · Cited by 174 · see citing works
Reinmuth, N., Fan, F., Liu, W., Parikh, A. A., Stoeltzing, O., Jung, Y. D., Bucana, C. D., Radinsky, R., Gallick, G. E., & Ellis, L. M. (2002) · Laboratory Investigation · doi:10.1097/01.lab.0000032411.41603.c2 · Cited by 174 · see citing works
Constitutive Expression of Multiple Growth Factor Genes by Melanoma Cells but Not Normal Melanocytes
Rodeck, U., Melber, K., Kath, R., et al. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12477822 · Cited by 172 · see citing works
Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?
Hoeflich, A., Reisinger, R., Lahm, H., Kiess, W., Blum, W. F., Kolb, H. J., Weber, M. M., & Wolf, E. (2001) · PubMed · Cited by 169 · see citing works
Lewis, D. A., Travers, J. B., Somani, A.-K., & Spandau, D. F. (2009) · Oncogene · doi:10.1038/onc.2009.440 · Cited by 166 · see citing works
Overexpression of the insulin‐like growth factor I receptor in human colon carcinomas
Weber, M. M., Fottner, C., Liu, S. B., et al. (2002) · Cancer · doi:10.1002/cncr.10945 · Cited by 165 · see citing works
Krueckl, S. L., Sikes, R. A., Edlund, N. M., Bell, R. H., Hurtado‐Coll, A., Fazli, L., Gleave, M. E., & Cox, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-2446 · Cited by 163 · see citing works
Tennant, M. K., Thrasher, J. B., Twomey, P. A., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855837 · Cited by 162 · see citing works
Agalliu, I., Gapstur, S. M., Chen, Z., et al. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2015.5504 · Cited by 162 · see citing works
BRCA mutations in the management of breast cancer: the state of the art
Narod, S. A. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.166 · Cited by 160 · see citing works
Satyamoorthy, K., Li, G., Vaidya, B., Patel, D., & Herlyn, M. (2001) · PubMed · Cited by 159 · see citing works
Miyamoto, S., Yano, K., Sugimoto, S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-1916 · Cited by 153 · see citing works
Expression of the insulin-like growth factors and their receptors in adenocarcinoma of the colon
Freier, S., Weiss, O., Eran, M., Flyvbjerg, A., Dahan, R., Nephesh, I., Safra, T., Shiloni, E., & Raz, I. (1999) · Gut · doi:10.1136/gut.44.5.704 · Cited by 150 · see citing works
Model systems of human papillomavirus‐associated disease
Doorbar, J. (2015) · The Journal of Pathology · doi:10.1002/path.4656 · Cited by 146 · see citing works
Human papillomavirus and cervical cancer
Reeves, W. C. (1990) · Virus Research · doi:10.1016/0168-1702(90)90026-8 · Cited by 143 · see citing works
Rodeck, U., Herlyn, M., Menssen, H. D., Furlanetto, R. W., & Koprowski, H. (1987) · International Journal of Cancer · doi:10.1002/ijc.2910400520 · Cited by 143 · see citing works
Insulin-like Growth Factor Receptor as a Therapeutic Target in Head and Neck Cancer
Barnes, C. J., Ohshiro, K., Rayala, S. K., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2040 · Cited by 141 · see citing works
Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes
Yerushalmi, R., Gelmon, K. A., Leung, S. C. Y., et al. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1529-8 · Cited by 140 · see citing works
Circulating levels of insulin‐like growth factor‐I and risk of ovarian cancer
Lukanova, A., Lundin, E., Toniolo, P. G., Micheli, A., Akhmedkhanov, A., Rinaldi, S., Muti, P. C., Lenner, P., Biessy, C., Krogh, V., et al. (2002) · International Journal of Cancer · doi:10.1002/ijc.10613 · Cited by 140 · see citing works
Luo, M., Shen, D., Zhou, X., et al. (2013) · Surgery · doi:10.1016/j.surg.2012.12.004 · Cited by 139 · see citing works
Chang, Y. S., Wang, L., Liu, D., Mao, L., Hong, W. K., Khuri, F. R., & Lee, H. (2002) · PubMed · Cited by 136 · see citing works
McCampbell, A. S., Broaddus, R. R., Loose, D. S., & Davies, P. J. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0912 · Cited by 134 · see citing works
Insulin-like growth factors in endometrial function
Rutanen, E. ‐. (1998) · Gynecological Endocrinology · doi:10.3109/09513599809012842 · Cited by 134 · see citing works
Hodak, E., Gottlieb, A. B., Anzilotti, M., & Krueger, J. G. (1996) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12344044 · Cited by 130 · see citing works
Probst-Hensch, N. M., Yuan, J.-M., Stanczyk, F. Z., et al. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.2172 · Cited by 127 · see citing works
Hepatocellular carcinoma: Where are we?
Mazzanti, R. (2016) · World Journal of Experimental Medicine · doi:10.5493/wjem.v6.i1.21 · Cited by 126 · see citing works
Su, Y., Wagner, E. R., Luo, Q., et al. (2011) · Oncogene · doi:10.1038/onc.2011.97 · Cited by 124 · see citing works
Dziadziuszko, R., Merrick, D. T., Witta, S. E., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6611 · Cited by 124 · see citing works
Sandberg, A.-C., Engberg, C., Lake, M., von Holst, H., & Sara, V. R. (1988) · Neuroscience Letters · doi:10.1016/0304-3940(88)90022-5 · Cited by 123 · see citing works
Guo, W., Lonardo, F., Ueda, T., Kim, T. K., Huvos, A. G., Healey, J. H., & Ladanyi, M. (1999) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19990118)80:2 · Cited by 120 · see citing works
The aging of the 2000 and 2011 Hallmarks of Cancer reviews: A critique
Sonnenschein, C., & Soto, A. M. (2013) · Journal of Biosciences · doi:10.1007/s12038-013-9335-6 · Cited by 119 · see citing works
Lahm, H., Suardet, L., Pl, L., Fischer, J., Ceyhan, A., Givel, J.-C., & Odartchenko, N. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.69 · Cited by 118 · see citing works
Ludovini, V., Bellezza, G., Pistola, L., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdn727 · Cited by 116 · see citing works
Tennant, M. K., Thrasher, J. B., Twomey, P. A., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.1.8550786 · Cited by 114 · see citing works
Flyvbjerg, A., Mogensen, O. E., Mogensen, B., et al. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4085 · Cited by 114 · see citing works
Shimizu, C., Hasegawa, T., Tani, Y., et al. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.09.005 · Cited by 109 · see citing works
Head and Neck Cancer: Recent Advances and New Standards of Care
Forastiere, A. A., Trotti, A., Pfister, D. G., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.1464 · Cited by 108 · see citing works
Peters, G., Gongoll, S., Langner, C., Mengel, M., Piso, P., Klempnauer, J. L., Rüschoff, J., Kreipe, H. H., & von Wasielewski, R. (2003) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-003-0856-5 · Cited by 106 · see citing works
Hilmi, C., Larribère, L., Giuliano, S., Bille, K., Ortonne, J. P., Ballotti, R., & Bertolotto, C. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701185 · Cited by 104 · see citing works
Insulin-like growth factor-I regulates GPER expression and function in cancer cells
Marco, P. D., Bartella, V., Vivacqua, A., Lappano, R., Santolla, M. F., Morcavallo, A., Pezzi, V., Belfiore, A., & Maggiolini, M. (2012) · Oncogene · doi:10.1038/onc.2012.97 · Cited by 101 · see citing works
Insulin-like growth factor-binding proteins: functional diversity or redundancy?
Murphy, L. (1998) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0210097 · Cited by 101 · see citing works
Yi, H., Hwang, P. H., Yang, D.-H., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(01)00269-6 · Cited by 100 · see citing works
Liao, Y., Abel, U. R., Grobholz, R., et al. (2005) · Human Pathology · doi:10.1016/j.humpath.2005.07.023 · Cited by 100 · see citing works
Mazziotti, G., Sorvillo, F., Morisco, F., Carbone, A., Rotondi, M., Stornaiuolo, G., Precone, D. F., Cioffi, M., Gaeta, G. B., Caporaso, N., et al. (2002) · Cancer · doi:10.1002/cncr.11002 · Cited by 99 · see citing works
Bauer, T. W., Somcio, R., Fan, F., Liu, W., Johnson, M., Lesslie, D. P., Evans, D. B., Gallick, G. E., & Ellis, L. M. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0175 · Cited by 99 · see citing works
Hemers, E., Duval, C., McCaig, C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0157 · Cited by 98 · see citing works
Scagliotti, G. V., & Novello, S. (2011) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.07.008 · Cited by 96 · see citing works
Yao, X., Hu, J., Daniels, M., Shiran, H., Zhou, X., Yan, H., Lü, H., Zeng, Z., Wang, Q., Li, T., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15109 · Cited by 96 · see citing works
Novel stimulatory role for insulin‐like growth factor binding protein‐2 in prostate cancer cells
Moore, M. G., Wetterau, L. A., Francis, M. J., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11015 · Cited by 95 · see citing works
Karasik, A., Menczer, J., Pariente, C., et al. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.78.2.7508947 · Cited by 95 · see citing works
Mannhardt, B., WEINZIMER, S. A., Wagner, M., Fiedler, M., Cohen, P., Jansen‐Dürr, P., & Zwerschke, W. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.17.6483-6495.2000 · Cited by 94 · see citing works
Tennant, M. K. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3774 · Cited by 94 · see citing works
Sayer, R. A., Lancaster, J. M., Pittman, J., et al. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.10.012 · Cited by 93 · see citing works
Huynh, H. T., Chow, P. K. H., Ooi, L. L., & Soo, K. C. (2002) · PubMed · Cited by 93 · see citing works
Relevance of biologic markers in colorectal carcinoma
Barozzi, C., Ravaioli, M., D’Errico, A., et al. (2002) · Cancer · doi:10.1002/cncr.10278 · Cited by 92 · see citing works
Sureshbabu, A., Okajima, H., Yamanaka, D., Tonner, E., Shastri, S., Maycock, J., Szymanowska, M., Shand, J. H., Takahashi, S., Beattie, J., et al. (2012) · Journal of Cell Science · doi:10.1242/jcs.092882 · Cited by 90 · see citing works
Cardillo, M. R., Monti, S., Silverio, F. D., Gentile, V., Sciarra, F., & Toscano, V. (2003) · PubMed · Cited by 89 · see citing works
Prediagnostic plasma IGFBP ‐1, IGF ‐1 and risk of prostate cancer
Cao, Y., Nimptsch, K., Shui, I. M., Platz, E. A., Wu, K., Pollak, M., Kenfield, S. A., Stampfer, M. J., & Giovannucci, E. L. (2014) · International Journal of Cancer · doi:10.1002/ijc.29295 · Cited by 88 · see citing works
Transcripts of the insulin-like growth factors I and II in human hepatoma.
Su, T., Liu, W. Y., Han, S. H., et al. (1989) · PubMed · Cited by 86 · see citing works
Alajez, N. M., Shi, W., Wong, D., Lenarduzzi, M., Waldron, J. N., Weinreb, I., & Liu, F. (2012) · Oncotarget · doi:10.18632/oncotarget.785 · Cited by 85 · see citing works
Tavakkol, A., Varani, J., Elder, J. T., et al. (1999) · Archives of Dermatological Research · doi:10.1007/s004030050469 · Cited by 84 · see citing works
Lin, Y., Tamakoshi, A., Kikuchi, S., Yagyu, K., Obata, Y., Ishibashi, T., Kawamura, T., Inaba, Y., Kurosawa, M., Motohashi, Y., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20147 · Cited by 83 · see citing works
Karna, E., Surażyński, A., Orłowski, K., Łaszkiewicz, J., Puchalski, Z., Nawrat, P., & Palka, J. A. (2002) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2002.00237.x · Cited by 82 · see citing works
Shen, M., Hsu, Y.-M., Hsu, K., Chen, Y., Tang, M., & Chou, C.-Y. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi336 · Cited by 82 · see citing works
Ayabe, T., Tsutsumi, O., Sakai, H., et al. (1997) · Endocrine Journal · doi:10.1507/endocrj.44.419 · Cited by 81 · see citing works
Heidegger, I. M., Kern, J., Ofer, P., Klocker, H., & Massoner, P. (2014) · Oncotarget · doi:10.18632/oncotarget.1884 · Cited by 80 · see citing works
IGF-I in epithelial ovarian cancer and its role in disease progression
Brokaw, J. L., Katsaros, D., Wiley, A., et al. (2007) · Growth Factors · doi:10.1080/08977190701838402 · Cited by 80 · see citing works
Yao, X., Hu, J., Daniels, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200315109 · Cited by 80 · see citing works
Weber, A., Bellmann, U., Bootz, F., Wittekind, C., & Tannapfel, A. (2002) · International Journal of Cancer · doi:10.1002/ijc.10296 · Cited by 79 · see citing works
Barton, E. R., DeMeo, J., & Lei, H. (2010) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01308.2009 · Cited by 78 · see citing works
Kim, W.-Y., Jin, Q., Oh, S.-H., Kim, E. S., Yang, Y. J., Lee, D. H., Feng, L., Behrens, C., Prudkin, L., Miller, Y. E., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3792 · Cited by 78 · see citing works
Shafiee, M. N., Seedhouse, C., Mongan, N. P., Chapman, C. J., Deen, S., Abu, J., & Atiomo, W. (2016) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.01.019 · Cited by 78 · see citing works
Pavelić, K., Kolak, T., Kapitanović, S., et al. (2003) · The Journal of Pathology · doi:10.1002/path.1465 · Cited by 77 · see citing works
Cappuzzo, F., Tallini, G., Finocchiaro, G., Wilson, R. S., Ligorio, C., Giordano, L., Toschi, L., Incarbone, M., Cavina, R., Terracciano, L., et al. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp357 · Cited by 76 · see citing works
RNA splicing factors regulated by HPV16 during cervical tumour progression
Mole, S., McFarlane, M., Chuen‐Im, T., Milligan, S. G., Millan, D. W. M., & Graham, S. V. (2009) · The Journal of Pathology · doi:10.1002/path.2608 · Cited by 75 · see citing works
Chi, F., Wu, R., Zeng, Y., et al. (2012) · Molecular Biology Reports · doi:10.1007/s11033-012-2432-z · Cited by 74 · see citing works
Clinical and Biological Implications of the Tumor Microenvironment
Jackson, D. G. (2012) · Cancer Microenvironment · doi:10.1007/s12307-012-0099-6 · Cited by 73 · see citing works
Weiderpass, E., Brismar, K., Bellocco, R., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601312 · Cited by 73 · see citing works
Nosho, K., Yamamoto, H., Taniguchi, H., Adachi, Y., Yoshida, Y., Arimura, Y., Endo, T., Hinoda, Y., & Imai, K. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0875 · Cited by 72 · see citing works
Han, V. K. M., Matsell, D. G., Delhanty, P. J. D., Hill, D. J., Shimasaki, S., & Nygard, K. L. (2008) · Hormone Research · doi:10.1159/000184780 · Cited by 70 · see citing works
Shiratsuchi, I., Akagi, Y., Kawahara, A., Kinugasa, T., Romeo, K., Yoshida, T., Ryu, Y., Gotanda, Y., Kage, M., & Shirouzu, K. (2011) · PubMed · Cited by 70 · see citing works
Wu, X., Zhao, H., Do, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0762 · Cited by 70 · see citing works
Sonnenschein, C., Soto, A. M., Rangarajan, A., & Kulkarni, P. (2014) · Journal of Biosciences · doi:10.1007/s12038-013-9403-y · Cited by 69 · see citing works
Endometrial Cancer and the IGF System: A Case-Control Study in Greece
Petridou, E. T., Koukoulomatis, P., Alexe, D. M., Voulgaris, Z., Spanos, E., & Trichopoulos, D. (2003) · Oncology · doi:10.1159/000070291 · Cited by 68 · see citing works
Zeng, H., Datta, K., Neid, M., Li, J., Parangi, S., & Mukhopadhyay, D. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00107-4 · Cited by 67 · see citing works
Li, S., Goko, H., Xu, Z., et al. (1998) · Cell and Tissue Research · doi:10.1007/s004410051016 · Cited by 66 · see citing works
Novel insights into the implication of the IGF-1 network in prostate cancer
Papatsoris, A., Karamouzis, M. V., & Papavassiliou, A. G. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.12.005 · Cited by 66 · see citing works
Weng, C., Hsieh, Y., Tsai, C., Chu, Y.-H., Ueng, K., Liu, Y., Yeh, Y.-H., Su, S., Chen, Y., Chen, M., et al. (2010) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0904-8 · Cited by 66 · see citing works
Expression of insulin-like growth factor-1 receptor in local and metastatic prostate cancer
Ryan, C. J., Haqq, C. M., Simko, J. P., et al. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2006.07.019 · Cited by 66 · see citing works
Kaaks, R., Johnson, T., Tikk, K., Sookthai, D., Tjønneland, A. M., Roswall, N., Overvad, K., Clavel‐Chapelon, F., Boutron‐Ruault, M., Dossus, L., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28589 · Cited by 65 · see citing works
Wolpin, B. M., Michaud, D. S., Giovannucci, E. L., et al. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603826 · Cited by 65 · see citing works
EL-Mesallamy, H. O., Hamdy, N. Μ., Zaghloul, A. S., & Sallam, A.-A. M. (2012) · Pancreas · doi:10.1097/mpa.0b013e3182550d9d · Cited by 65 · see citing works
IGF axis gene expression patterns are prognostic of survival in epithelial ovarian cancer
Spentzos, D., Cannistra, S. A., Grall, F. T., et al. (2007) · Endocrine Related Cancer · doi:10.1677/erc-06-0073 · Cited by 65 · see citing works
Hoeflich, A., & Russo, V. C. (2015) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2015.07.002 · Cited by 64 · see citing works
Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC)
Scharf, J. (1998) · Carcinogenesis · doi:10.1093/carcin/19.12.2121 · Cited by 64 · see citing works
Han, J., Jogie‐Brahim, S., Harada, A., et al. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.04.004 · Cited by 64 · see citing works
Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis
Wu, Y. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i18.2740 · Cited by 63 · see citing works
Nakamura, K., Hongo, A., Kodama, J., Miyagi, Y., Yoshinouchi, M., & Kudo, T. (2000) · PubMed · Cited by 63 · see citing works
Durrant, L., Watson, S., Hall, A., et al. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.14 · Cited by 63 · see citing works
Marcelli, M., Haidacher, S. J., Plymate, S. R., et al. (1995) · Endocrinology · doi:10.1210/endo.136.3.7532576 · Cited by 62 · see citing works
Luther, G. A., Lamplot, J. D., Chen, X., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.05.002 · Cited by 61 · see citing works
BAHHNASSY, A., Mohanad, M., Shaarawy, S., et al. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.3560 · Cited by 60 · see citing works
Expression of insulin-like growth factor receptors I and II in normal human lung and in lung cancer
Kaiser, U., Schardt, C., Brandscheidt, D., Wollmer, E., & HAVEMANN, K. (1993) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01215985 · Cited by 60 · see citing works
Tennant, M. K., Thrasher, J. B., Twomey, P. A., et al. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.10.8855838 · Cited by 60 · see citing works
Hirano, S., Ito, N., Takahashi, S., et al. (2004) · PubMed · Cited by 60 · see citing works
Laron Syndrome - From Man to Mouse
Laron, Z., & Kopchick, J. (2010) · Springer eBooks · doi:10.1007/978-3-642-11183-9 · Cited by 60 · see citing works
Insulin-like growth factors and their binding proteins in prostate cancer: Cause or consequence?☆
Meinbach, D. S., & Lokeshwar, B. L. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.12.004 · Cited by 59 · see citing works
Bauer, T. W., Fan, F., Liu, W., Johnson, M., Parikh, N. U., Parry, G. C., Callahan, J. A., Mazar, A. P., Gallick, G. E., & Ellis, L. M. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000160699.59061.92 · Cited by 59 · see citing works
Michell, N. P., LANGMAN, M. J. S., & Eggo, M. C. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.337 · Cited by 59 · see citing works
MATHUR, S. P., Mathur, R. S., Gray, E. A., et al. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.05.003 · Cited by 59 · see citing works
Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma
Gao, Y., Katki, H. A., Graubard, B. I., Pollak, M., Martin, M., Tao, Y., Schoen, R. E., Church, T. R., Hayes, R. B., Greene, M. H., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26438 · Cited by 59 · see citing works
Marimuthu, A., Chavan, S., Sathe, G. J., Sahasrabuddhe, N. A., Manda, S. S., Renuse, S., Ahmad, S., Radhakrishnan, A., Barbhuiya, M. A., Kumar, R. V., et al. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2013.04.029 · Cited by 58 · see citing works
Li, Z.-J. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i43.7788 · Cited by 58 · see citing works
Yeo, C. D., Park, K. H., Park, C. K., Lee, S. H., Kim, S. J., Yoon, H. K., Lee, Y. S., Lee, E. J., Lee, K. Y., & Kim, T. J. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.01.004 · Cited by 58 · see citing works
Chen, H., Zhu, B., Zhang, C., et al. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02129.x · Cited by 56 · see citing works
Pavelić, J., Radaković, B., & Pavelić, K. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.02.012 · Cited by 56 · see citing works
Insulin-like growth factor-1 receptor and ligand targeting in head and neck squamous cell carcinoma
Slomiany, M. G., Black, L., Kibbey, M. M., et al. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.08.004 · Cited by 56 · see citing works
Association between Circulating Levels of IGF-1 and IGFBP-3 and Lung Cancer Risk: A Meta-Analysis
Cao, H., Wang, G., Meng, L., Shen, H., Feng, Z., Liu, Q., & Du, J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049884 · Cited by 56 · see citing works
King, E. R., Zu, Z., Tsang, Y. T. M., Deavers, M. T., Malpica, A. L., Mok, S. C., Gershenson, D. M., & Wong, K. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.06.016 · Cited by 56 · see citing works
Role of IGF-1/IGF-1R in regulation of invasion in DU145 prostate cancer cells
Saikali, Z., Setya, H. C., Singh, G., et al. (2008) · Cancer Cell International · doi:10.1186/1475-2867-8-10 · Cited by 56 · see citing works
Ueda, S., Hatsuse, K., Tsuda, H., et al. (2006) · Modern Pathology · doi:10.1038/modpathol.3800582 · Cited by 55 · see citing works
Rehem, R. A., & El-Shikh, W. (2011) · PubMed · Cited by 54 · see citing works
Bodaghi, S., Jia, R., & Zheng, Z. (2009) · Virology · doi:10.1016/j.virol.2008.12.037 · Cited by 54 · see citing works
Faye, M. D., Beug, S. T., Graber, T. E., Earl, N., Xiang, X., Wild, B., Langlois, S. D., Michaud, J., Cowan, K. N., Korneluk, R. G., et al. (2014) · Oncogene · doi:10.1038/onc.2014.90 · Cited by 54 · see citing works
Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk
Feik, E., Baierl, A., Hieger, B., et al. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9438-4 · Cited by 54 · see citing works
IGF-1 induced vascular endothelial growth factor secretion in head and neck squamous cell carcinoma
Slomiany, M. G., Black, L., Kibbey, M. M., Day, T. A., & Rosenzweig, S. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.02.043 · Cited by 53 · see citing works
Clinical Significance of IGF1R Expression in Non–Small-Cell Lung Cancer
Nakagawa, M., Uramoto, H., Oka, S., et al. (2012) · Clinical Lung Cancer · doi:10.1016/j.cllc.2011.10.006 · Cited by 53 · see citing works
Armakolas, A., Philippou, Α., Panteleakou, Z., et al. (2010) · The Prostate · doi:10.1002/pros.21158 · Cited by 53 · see citing works
The expression of insulin-like growth factor binding proteins in human hepatocellular carcinoma
Gong, Y., Cui, L., & Minuk, G. Y. (2000) · Molecular and Cellular Biochemistry · doi:10.1023/a:1007010818094 · Cited by 52 · see citing works
Flossmann-Kast, B. B. M., Jehle, P. M., Hoeflich, A., Adler, G., & Lutz, M. P. (1998) · PubMed · Cited by 52 · see citing works
Badzio, A., Badzio, A., Wynes, M. W., et al. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181f38f57 · Cited by 52 · see citing works
Clinical implications of insulin-like growth factor 1 system in early-stage cervical cancer
Yf, H., Shen, M.-R., Hsu, K.-F., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604661 · Cited by 52 · see citing works
Thompson, M., Cox, A. J., Whitehead, R. H., & Jonas, H. A. (1990) · Endocrinology · doi:10.1210/endo-126-6-3033 · Cited by 52 · see citing works
Gately, K. A., Forde, L., Cuffe, S. D., et al. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.08.005 · Cited by 51 · see citing works
Human skin expresses growth hormone but not the prolactin gene
Slominski, A. T., Malarkey, W. B., Wortsman, J., et al. (2000) · Journal of Laboratory and Clinical Medicine · doi:10.1067/mlc.2000.110605 · Cited by 50 · see citing works
Su, W., Lee, K., Yeh, Y., Soon, M., Wang, C., Yu, M., & Wang, S. (2010) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.20320 · Cited by 50 · see citing works
Chung, C. K., & Antoniades, H. N. (1992) · PubMed · Cited by 49 · see citing works
Hung, P., Kao, S. Y., Shih, Y., Chiou, S., Liu, C., Chang, K., & Lin, S. (2007) · The Journal of Pathology · doi:10.1002/path.2280 · Cited by 49 · see citing works
Ge, J., Chen, Z., Wu, S., et al. (2009) · Digestion · doi:10.1159/000226089 · Cited by 48 · see citing works
Insulin-Like Growth Factor Axis Gene Polymorphisms and Clinical Outcomes in Pancreatic Cancer
Dong, X., Javle, M. M., Hess, K. R., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.04.042 · Cited by 48 · see citing works
IGF-I and IGFBP-3 and the risk of lung cancer: A meta-analysis based on nested case-control studies
Chen, B., Liu, S., Xu, W., et al. (2009) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-28-89 · Cited by 48 · see citing works
Dong, Z. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i30.4655 · Cited by 48 · see citing works
Are the Somatic Mutation and Tissue Organization Field Theories of Carcinogenesis Incompatible?
Rosenfeld, S. (2013) · Cancer Informatics · doi:10.4137/cin.s13013 · Cited by 47 · see citing works
Lund, P., Schubert, D., Niketeghad, F., et al. (2003) · Cancer Letters · doi:10.1016/j.canlet.2003.10.018 · Cited by 47 · see citing works
Villani, R. M., Adolphe, C., Palmer, J. S., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0082 · Cited by 47 · see citing works
Nucleolar localization of an isoform of the IGF-I precursor
Tan, D. S. W., Cook, A. R., & Chew, S. L. (2002) · BMC Cell Biology · doi:10.1186/1471-2121-3-17 · Cited by 46 · see citing works
Analysis of variables affecting wound healing after musculoskeletal sarcoma resections
Chmell, M. J., & Schwartz, H. S. (1996) · Journal of Surgical Oncology · doi:10.1002/(sici)1096-9098(199603)61:3 · Cited by 46 · see citing works
Kasprzak, A., & Adamek, A. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1666 · Cited by 46 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Insulin-Like Growth Factor (IGF) System in Liver Diseases
Adamek, A., & Kasprzak, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051308 · Cited by 284 · see citing works
Self-citationInsulin-Like Growth Factor 1 (IGF-1) Signaling in Glucose Metabolism in Colorectal Cancer
Kasprzak, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22126434 · Cited by 248 · see citing works
Self-citationSantonocito, S., Giudice, A., Polizzi, A., Troiano, G., Merlo, E. M., Sclafani, R., Grosso, G., & Isola, G. (2022) · Nutrients · doi:10.3390/nu14122426 · Cited by 144 · see citing works
Dietary Factors Affecting the Prevalence and Impact of Periodontal Disease
Santonocito, S., Polizzi, A., Palazzo, G., Indelicato, F., & Isola, G. (2021) · Clinical Cosmetic and Investigational Dentistry · doi:10.2147/ccide.s288137 · Cited by 55 · see citing works
Peinetti, N., Cuello Rubio, M. M., Sosa, L. D. V., Scalerandi, M. V., Alasino, R. V., Peyret, V., Nicola, J. P., Beltramo, D. M., Quintar, A. A., & Maldonado, C. A. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119985 · Cited by 7 · see citing works
- Authors
- Kasprzak, A., Kwasniewski, W., Adamek, A., & Gozdzicka-Jozefiak, A.
- Affiliations
- Poznan University of Medical Sciences (PL)
- Corresponding author
- Kasprzak, Aldona
- Venue
- Mutation Research/Reviews in Mutation Research
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 772
- Pages
- 78-104
- ISSN
- 1383-5742 (ISSN-L)
- OpenAlex
- W2517957586
- Cited by
- 130
- References
- 404
- Citations by year
- 2026: 3 · 2025: 8 · 2024: 5 · 2023: 15 · 2022: 16 · 2021: 22 · 2020: 17 · 2019: 21 · 2018: 17 · 2017: 6
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Mutation Research/Reviews in Mutation Research (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin-like growth factor, IGF axis, carcinogenesis, insulin-like growth factor I, IGF-1 receptor, PI3K/Akt signaling, cell proliferation, apoptosis inhibition, metastasis, tumor markers, prognostic factors, anti-tumor therapy, sex hormones, suppressor genes, lifestyle factors, human cancer
- MeSH terms
- Female, Gastrointestinal Neoplasms, Head and Neck Neoplasms, Humans, Insulin-Like Growth Factor I, Lung Neoplasms, Phosphorylation, Skin Neoplasms, Meta-Analysis as Topic, Signal Transduction, Receptors, Somatomedin, Insulin-Like Growth Factor Binding Proteins, Papillomaviridae, Cell Line, Tumor, Carcinogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review